Diagnostik und Therapie der primär biliären Zirrhose und der primär sklerosierenden Cholangitis

Deutsche Medizinische Wochenschrift

Volumn 128, Issue , 2003, Pages 96-98

  Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; COLESTYRAMINE; METRONIDAZOLE; NALTREXONE; ONDANSETRON; PROPOFOL; RIFAMPICIN; TERFENADINE; URSODEOXYCHOLIC ACID; VASOPRESSIN; VITAMIN D;

BILE DUCT CARCINOMA; CLINICAL FEATURE; COLORECTAL CANCER; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; OSTEOPOROSIS; PLASMAPHERESIS; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; SJOEGREN SYNDROME; WESTERN BLOTTING;

AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION;

EID: 0038606967     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-2003-40161     Document Type: Article

References (12)

1. Bergquist A et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321-327
2. Boberg KM et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002; 37: 1205-1211
3. Broome U et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002; 36: 586-589
4. Graziadeii W. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575-581
5. Harnois DM et al. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001; 96: 1558-1562
6. Liermann Garcia RF et al. Transplantation for primary biliary cirrhosis: retrospective analysis of400 patients in a single center. Hepatology 2001; 33: 22-27
7. Poupon RE, Bonnand AM, Chretien Y, Poupon R, The UDCA-PBC Study Group. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology 1999; 29: 1668-1671
8. Stiehl A et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002; 36: 151-156
9. Strassburg CP et al. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 595-601
10. Strassburg CP, Obermayer-Straub P, Manns MP. Autoimmunity in liver diseases. Clin Rev Allergy Immunol 2000: 127-139
11. Tung BY et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001; 134: 89-95
12. Vogel A, Wedemeyer HMPM, Strassburg CP. Autoimmune hepatitis and overlap syndromes. J Gastroenterol Hepatol 2002 (Suppl 3); 17: S389-S398